This may potentially include complement deficiencies (using DBS eluates as described by Janzi et al. [41] for C3 deficiencies and Hamsten et al. [42] for C2 deficiencies) and granulocyte defects, thus allowing coverage of a majority of the primary immunodeficiency diseases. Here, C3 is linked to complement deficiency.